CLINICAL AND PHARMACOLOGICAL STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED BREAST-CANCER

被引：0
|
作者：
BECHER, R [1 ]
MILLER, AA [1 ]
GERHOLD, U [1 ]
HOFFKEN, K [1 ]
SCHMIDT, CG [1 ]
机构：
[1] UNIV ESSEN GESAMTHSCH KLINIKUM,W DEUTSCH TUMORZENTRUM,INNERE CLIN & POLICLIN,TUMORFORSCH,D-4300 ESSEN 1,FED REP GER
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [21] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN HEAVILY PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER
    GOSS, PE
    ASHLEY, S
    POWLES, TJ
    COOMBES, RC
    CANCER TREATMENT REPORTS, 1986, 70 (06): : 777 - 779
  • [22] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE CAUSES ADRENAL SUPPRESSION IN PATIENTS WITH BREAST-CANCER
    VANVEELEN, H
    HOUWERZIJL, J
    RODING, TJ
    TJABBES, T
    VERMEER, RJI
    SLEIJFER, DT
    PRATT, JJ
    WILLEMSE, PHB
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (10): : 1035 - 1036
  • [23] 5-FLUOROURACIL, ADRIAMYCIN AND CYCLOPHOSPHAMIDE COMBINED WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    LOPEZ, M
    DILAURO, L
    PERNO, CF
    PAPALDO, P
    BARDUAGNI, M
    BARDUAGNI, A
    TUMORI, 1983, 69 (06) : 545 - 551
  • [24] CHEMOTHERAPY WITH OR WITHOUT HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ESTROGEN-RECEPTOR-NEGATIVE ADVANCED BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    KLEPP, O
    LUND, E
    HANNISDAL, E
    HOST, H
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) : 390 - 394
  • [25] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [26] SEQUENTIAL COMBINATION OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE - THERAPEUTIC AND ENDOCRINE EFFECTS IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS
    GASPARINI, G
    CANOBBIO, L
    GALLIGIONI, E
    FASSIO, T
    BREMA, F
    CRIVELLARI, D
    VILLALTA, D
    DIFRONZO, G
    TALAMINI, R
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (10): : 1451 - 1459
  • [27] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER RESISTANT TO ENDOCRINE AND CYTOTOXIC THERAPY
    DELENA, M
    BRAMBILLA, C
    VALAGUSSA, P
    BONADONNA, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) : 175 - 180
  • [28] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN - A RANDOMIZED CROSSOVER TRIAL IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    VANVEELEN, H
    WILLEMSE, PHB
    TJABBES, T
    SCHWEITZER, MJH
    SLEIJFER, DT
    CANCER, 1986, 58 (01) : 7 - 13
  • [29] WEEKLY DOXORUBICIN WITH OR WITHOUT HIGH-DOSE A MEDROXYPROGESTERONE ACETATE IN HORMONE-RESISTANT ADVANCED BREAST-CANCER - A RANDOMIZED STUDY
    GUNDERSEN, S
    HANNISDAL, E
    LUNDGREN, S
    WIST, E
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) : 1775 - 1778
  • [30] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED PROSTATIC-CANCER
    SULMONI, M
    PFENNINGER, R
    MULLER, J
    BANDHAUER, K
    AKTUELLE UROLOGIE, 1993, 24 (06) : 334 - 337
12345